Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Interventional Study of Stereotactic Body RadioTherapy (SBRT) With Continuous Tracking for Inoperable Patients With Primary and Secondary Renal Cancer (SBRTRC)

NCT07285538 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT07285538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07285538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Interventional Study of Stereotactic Body RadioTherapy (SBRT) With Continuous Tracking for Inoperable Patients With Primary and Secondary Renal Cancer (SBRTRC)
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
January 15, 2033
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cancer, renal secondary cancer, stereotactic body radiotherapy